Espumizan capsules 40mg №25×1

Name:
Espumizan capsules 40mg in blister packs №25×1
Description:
Gelatin capsules, round, with a seam and a smooth surface, yellow; the contents of the capsules are a colorless, viscous, slightly opalescent liquid. The main active ingredient Simethicone Release formCapsules are gelatinous, round, with a seam and a smooth surface, yellow; the contents of the capsules are a colorless, viscous, slightly opalescent liquid. 1 caps. Active substance: simethicone 40 mg; Excipients: gelatin – 22.47 mg, glycerol 85% – 9.67 mg, methyl parahydroxybenzoate – 0.28 mg, quinoline yellow dye (E104) – 0.1 mg, sunset yellow dye (E110) – 0.0024 mg. 25 pcs. – blisters (1) – packs of cardboard. 25 pcs. – blisters (2) – packs of cardboard. 25 pcs. – blisters (4) – packs of cardboard. Dosage 40 mg No. 25 Special instructions People with hypersensitivity to the components of the drug (methyl parahydroxybenzoate and quinoline yellow dye) may experience immediate-type hypersensitivity reactions, as well as delayed-type hypersensitivity reactions. If any allergic reactions occur, the drug should be stopped immediately and consult a doctor. Influence on the ability to drive vehicles and control mechanisms The drug Espumizan® does not affect the speed of psychomotor reactions and the ability to perceive or assess the situation. Pharmacological action Carminative. The active ingredient, simethicone, has surface activity and the ability to reduce surface tension at the liquid/gas interface. In this case, the gas bubbles merge and the foam is destroyed, as a result of which the released gas gets the opportunity to be absorbed or excreted naturally under the influence of intestinal motility. The use of Espumizan® in preparation for diagnostic studies prevents the occurrence of image defects caused by gas bubbles. Pharmacokinetics Simethicone is chemically inert, after oral administration it is not absorbed from the gastrointestinal tract and acts only in its lumen. Does not affect the enzymes and microorganisms present in the gastrointestinal tract. It is displayed unchanged. Indications for use Excessive formation and accumulation of gases in the gastrointestinal tract (flatulence, Remheld’s syndrome, aerophagia, increased gas formation in the postoperative period); preparation for diagnostic examinations of the abdominal cavity and small pelvis (including ultrasound, X-ray examinations); symptoms of excessive gas formation caused by functional dyspepsia; acute poisoning with detergents containing foaming substances (as a defoamer). Dosage and administration In case of complaints associated with excessive gas formation, adults and children over 6 years of age are prescribed 2 caps. 3-5 times / day, with a small amount of liquid, after each meal and, if necessary, at bedtime. The duration of the course of treatment depends on the presence of symptoms of increased gas formation. If necessary, the drug Espumizan® can be used for a long period of time. In preparation for diagnostic studies, 2 caps are prescribed. 3 times / day the day before the study and in the morning on the day of the study 2 capsules without drinking water. As a defoamer in case of poisoning with detergents containing foaming agents, a single dose for adults is 10-20 capsules, for children over 6 years old – 3-10 capsules. in one go; the dose depends on the severity of intoxication. Use during pregnancy and lactationEspumizan® can be used during pregnancy and during breastfeeding. Interaction with other drugs Clinically significant interaction of the drug Espumizan® with other drugs has not been established. Contraindications Intestinal obstruction; children’s age up to 6 years; hypersensitivity to the components of the drug. Composition Active substance: simethicone 40 mg; Excipients: gelatin – 22.47 mg, glycerol 85% – 9.67 mg, methyl parahydroxybenzoate – 0.28 mg, quinoline yellow dye (E104) – 0.1 mg, sunset yellow dye (E110) – 0.0024 mg. Overdose An overdose of Espumizan® is unlikely due to the chemical and physiological inertness of the drug. Side effects Side effects when taking the drug Espumizan® were not observed. Perhaps the development of allergic reactions to the auxiliary components of the drug. Storage conditions The drug should be stored out of the reach of children at a temperature not exceeding 30°C. Buy Espumizan capsules 40mg №25×1 Price for Espumizan capsules 40mg №25×1